EP Patent

EP0415766B1 — Use of retinoids for reversing glucocorticoid-induced skin atrophy

Assigned to Ortho Pharmaceutical Corp · Expires 1997-01-08 · 29y expired

What this patent protects

The present invention is directed to the topical administration of a retinoid-containing pharmaceutical composition for reversing the effects of glucocorticoid-induced skin atrophy.

USPTO Abstract

The present invention is directed to the topical administration of a retinoid-containing pharmaceutical composition for reversing the effects of glucocorticoid-induced skin atrophy.

Drugs covered by this patent

Patent Metadata

Patent number: EP0415766B1
Jurisdiction: EP
Classification: —
Expires: 1997-01-08
Drug substance claim: No
Drug product claim: No
Assignee: Ortho Pharmaceutical Corp
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.